Teva’s CGRP therapy becomes first approved option for children and adolescent
Promising results support global submissions and priority review by US FDA
Updated Date: Tue, 05 Aug 2025 00:00:00 EDT
Updated Date: Tue, 05 Aug 2025 00:00:00 EDT
Updated Date: Tue, 05 Aug 2025 00:00:00 EDT
Updated Date: Tue, 05 Aug 2025 00:00:00 EDT
Consumption ridden jails might conjure a Dickensian image, but a rise in tuberculosis (TB) cases in prisons is […]
Food insecurity is among the most pressing challenges of our time, persisting even when food is available. True […]
Pirtobrutinib meets primary endpoint in CLL/SLL study
Nationwide competition to pilot new models of obesity support